Therapeutics Initiative |

13 Nov [159] Escitalopram vs. citalopram: one enantiomer’s dominance reflects marketing, not evidence

Posted at 06:00h in Therapeutics Letter 0 Comments

13 Nov Comparative Analysis of the Efficacy and Safety of Various Single Enantiomer and Racemic Mixture Pairs

Posted at 08:01h in Drug Assessments 0 Comments

This is a systematic review conducted by the Drug Assessment Working Group of the Therapeutics Initiative. You can read the Abstract below. To view the complete report click on the DOWNLOAD button. Abstract Introduction: Chiral switching and single-isomer...

Anxiety Disorders Tag

13 Nov [159] Escitalopram vs. citalopram: one enantiomer’s dominance reflects marketing, not evidence

13 Nov Comparative Analysis of the Efficacy and Safety of Various Single Enantiomer and Racemic Mixture Pairs

Contact

Subscribe for Updates